The company develops and sells AI-based detection and tracking systems for the defense sector.
Axon Vision exited 2025 with genuine early commercialization signals, better gross profit, and a much stronger cash position, but still without proof that new orders will convert into profit and cash at a pace that justifies the cost base built during the year.
The CEO transition at Axon Vision improves the odds of commercialization mainly through a different management profile and a different incentive structure: a new CEO with a defense-sales background and an option package that can reach 2.08% on a fully diluted basis. It is a mate…
Axon Vision’s commercial traction is improving, but cash conversion is still lagging badly: in 2025 receivables, accrued income, and work in progress receivables rose far faster than revenue, and the January 2026 order shows that some 2026 cash may arrive only after installation.
